GPC1 and pancreatic neoplasm: Using a mixed model of GPC-1 expressing and KO pancreatic cancer cell line, it was shown that a humanized version of the MMAE ADC could significantly reduce tumor growth, while the ADC had no effect KO pancreatic cancer xenograft alone [57].